Compare Seed Co., Ltd. /7743/ with Similar Stocks
Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 3.00% and Operating profit at -1.01% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Capital Employed (avg) of 4.68% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 3.00% and Operating profit at -1.01% over the last 5 years
3
With a fall in EPS of -21.6%, the company declared Very Negative results in Mar 26
4
With ROCE of 4.68%, it has a fair valuation with a 0.96 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 14,770 Million (Small Cap)
15.00
NA
0.00%
0.83
6.08%
0.80
Revenue and Profits:
Net Sales:
8,419 Million
(Quarterly Results - Mar 2026)
Net Profit:
224 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.57%
0%
-17.57%
6 Months
-10.83%
0%
-10.83%
1 Year
12.05%
0%
12.05%
2 Years
-10.52%
0%
-10.52%
3 Years
-12.39%
0%
-12.39%
4 Years
2.45%
0%
2.45%
5 Years
-37.41%
0%
-37.41%
Seed Co., Ltd. /7743/ for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.00%
EBIT Growth (5y)
-1.01%
EBIT to Interest (avg)
6.33
Debt to EBITDA (avg)
3.38
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.89
Tax Ratio
17.04%
Dividend Payout Ratio
41.56%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
8.65%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.93
EV to EBIT
20.54
EV to EBITDA
6.70
EV to Capital Employed
0.96
EV to Sales
0.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.68%
ROE (Latest)
6.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
8,418.60
8,379.70
0.46%
Operating Profit (PBDIT) excl Other Income
1,066.30
987.20
8.01%
Interest
105.40
95.70
10.14%
Exceptional Items
0.50
0.20
150.00%
Consolidate Net Profit
223.90
74.30
201.35%
Operating Profit Margin (Excl OI)
17.20%
19.40%
-0.22%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.46% vs -2.52% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 201.35% vs -83.57% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
33,942.40
33,231.60
2.14%
Operating Profit (PBDIT) excl Other Income
4,755.10
4,947.00
-3.88%
Interest
393.10
337.50
16.47%
Exceptional Items
57.90
-8.70
765.52%
Consolidate Net Profit
1,133.60
1,100.50
3.01%
Operating Profit Margin (Excl OI)
42.40%
47.00%
-0.46%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 2.14% vs 2.58% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 3.01% vs -43.95% in Mar 2025
About Seed Co., Ltd. /7743/ 
Seed Co., Ltd. /7743/
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






